Keyword: Biotechnology

A new diagnostic assay, developed by MSc Md. Ferdhos Khan in his PhD study, will help to more accurately distinguish patients with prostate cancer from those with benign prostatic hyperplasia.

A simple laboratory test has been developed at the University of Turku, which can help to identify myocardial infarction patients more accurately and faster and thus improve patient care. Business Finland has granted funding for the SuperTROPO project, where the functionality of the test will be tested with extensive patient data.

A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency. Blood sample tests for cardiac troponins are an important cornerstone in the diagnostics of heart attack, but the result may be elevated also due to other transient or chronic conditions, such as renal insufficiency, atrial fibrillation or strenuous physical exercise. The new test may help in identifying myocardial infarction (MI) faster and more specifically and thus improve the treatment of MI patients.

A rapid test for ovarian cancer detection developed at the University of Turku has received the international Rapid Testing Innovation Award. The awarded article is part of the dissertation of Doctoral Candidate Sherif Bayoumy. Next, the cancer diagnostics team of the Biotechnology unit at the Department of Biochemistry aims to expand the research to other cancer types.

Researchers at the University of Turku, Finland, have developed a test for ovarian cancer detection with a sensitivity 4.5 times higher than that of the conventional laboratory test. The simple lateral flow test is based on rapid detection of abnormal sugar structures directly from the blood sample.